Who Researches This?
Who Researches Selank?
Selank is the peptide most people research when they want to take the edge off everyday anxiety, stress, and mental tension without feeling sedated or hooked. It sits at the center of the anxiety goal conversation, and it draws interest from people looking for an alternative to benzodiazepines, from those exploring the link between immune health and mood, and from anyone who wants calm without the mental fog. If the word "peptide" is brand new to you, start with our beginner's guide to peptides before going further. Selank is most often compared to its sister peptide Semax — Semax leans cognitive and stimulating, Selank leans calming — and the two are sometimes studied together in a nootropic stack. Go in clear-eyed: this is an approved drug in Russia but an unapproved research compound in the US, with real but small human evidence.
What Is Selank?
Plain-English version: Selank is a small, lab-made protein fragment (a "peptide") designed in Russia to calm anxiety. Scientists built it by taking a natural immune peptide called tuftsin and adding a short tail so it survives longer in the body.
Tuftsin is a four-amino-acid peptide (Thr-Lys-Pro-Arg) that your body makes by clipping it off an antibody protein (immunoglobulin G) in the spleen. On its own, tuftsin breaks down within minutes. Researchers added a Gly-Pro-Gly-Pro–style extension to make Selank, giving it the full sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, which resists enzymes long enough to reach the brain.[5] Selank is also known by its lab code TP-7.
Selank was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences together with the Zakusov Institute of Pharmacology. In Russia it completed clinical testing and is sold as a prescription intranasal (nasal-spray) medication for generalized anxiety disorder (GAD) and neurasthenia — an older term for stress-related nervous exhaustion.
What makes Selank interesting to researchers is that it appears to calm anxiety through a different route than benzodiazepines. Rather than switching on the brain's GABA "brake" the way Valium-type drugs do, it seems to nudge several systems gently at once. That multi-target style is the proposed reason it can reduce anxiety in trials while also showing mild stimulating ("antiasthenic") rather than sedating effects.[1]
The credibility caveat, stated up front: "approved in Russia" is not the same as "approved by the FDA." Selank has never been evaluated or approved by the FDA for any use, and it is not a lawfully marketed dietary supplement. A 2021 US pharmacology review flatly described it as being "inexplicably sold to US consumers as dietary supplements" despite that lack of review, and classed it among poorly studied GABAergic substances.[10] In the US it is sold labeled "for research use only." For the full legal breakdown, see Are Peptides Legal?
How Selank Works
Takeaway first: Selank does not have one clean "on switch." The best-supported idea is that it acts as a gentle tuner of the brain's GABA calming system, while also shifting serotonin, dopamine, and a growth factor called BDNF. Most of this evidence is from rats and cell cultures — the human mechanism work is thin. Here is what the verified research actually shows, and where it stops.
1. GABA system — gentle "allosteric" tuning (leading mechanism)
GABA is your brain's main calming chemical; it acts as a brake on overactive nerve signaling. Benzodiazepines grab a specific spot on the GABA-A receptor and crank that brake hard, which is why they can sedate and cause dependence. Selank appears to work more softly. Radioligand-binding studies reviewed in 2018 describe Selank as a subtype-selective, positive allosteric modulator of GABA receptors — meaning it fine-tunes the receptor's response rather than forcing it open, and it does not act at the benzodiazepine binding site.[5] Evidence level: in-vitro binding and review.
At the gene level, a single dose of Selank or GABA (300 µg/kg) altered the expression of 45 of 84 neurotransmission-related genes in the frontal cortex of rats at one hour, supporting the idea that Selank works through the GABAergic system rather than by directly plugging into a receptor.[3] A companion experiment in human IMR-32 nerve cells (a neuroblastoma cell line) found that Selank, GABA, and the antipsychotic olanzapine all shifted the expression of GABAergic genes, reinforcing that this pathway is central to how Selank acts.[4] Evidence level: rats plus a human cell line — not living people.
2. Enkephalins and the opioid link
Enkephalins are your body's own natural pain-and-mood-easing peptides. In the main human trial, Selank increased the half-life of leu-enkephalin in the blood — it lasted longer before being broken down — and that change tracked with the reduction in anxiety, suggesting the enkephalin system is part of the picture.[1] In rats, Selank's effect on dopamine-driven behavior was blocked by naloxone (an opioid blocker), which further points to an enkephalin/opioid pathway being involved.[8] Evidence level: one human trial plus rat behavior.
3. Serotonin and dopamine modulation
Serotonin and dopamine are mood, motivation, and focus chemicals. In mice, Selank changed the brain content of serotonin, dopamine, and their breakdown products, and — notably — the effect differed between mouse strains, hinting that genetics shape the response.[7] This helps explain the "calm but not sedated" profile, but it is animal data. Evidence level: mice.
4. BDNF — but "normalizing," not simply "boosting"
BDNF (brain-derived neurotrophic factor) is a protein that supports the survival and rewiring of neurons and underpins learning and memory. Selank is often described online as "raising BDNF," but the verified study is more precise: in rats, Selank (0.3 mg/kg/day for 7 days) had a cognitive-stimulating effect in aged animals and prevented the abnormal rise in hippocampal and frontal-cortex BDNF caused by alcohol withdrawal, while protecting memory and attention.[6] In other words, it regulated BDNF back toward normal rather than blindly increasing it. Evidence level: rats.
5. Immune modulation (from its tuftsin heritage)
Because Selank is built from tuftsin — an immune-signaling peptide — it retains some immune activity. In patients with anxiety-asthenic disorders, Selank suppressed IL-6 gene expression in blood cells at very low concentrations and shifted the balance of Th1/Th2 immune-signaling molecules over 14 days of dosing.[2] Reviewers describe it as an immunomodulator/adaptogen. Evidence level: small human study plus in-vitro.
What we do NOT know
There is no fully mapped human receptor target, no established human pharmacokinetics (how it is absorbed, distributed, and cleared in people), and no large human dose-response data. The mechanisms above are real published findings, but they are dominated by rat and cell work, and mechanism in animals does not guarantee benefit in humans.
Free · The Peptide Starter Kit
New to peptides?
Get the Peptide Starter Kit — the five best compounds for beginners, what each one does, and how to run them safely.
No spam · Unsubscribe anytime
Benefits & What the Research Shows
How to read this section: for each area we give the plain-English claim, the proposed mechanism, the population actually studied, the observed effect, and the limitation. Selank has more genuine human data than most research peptides — but "human data" here means a small number of Russian studies, the largest with 62 patients. Treat everything as preliminary.
Anxiety relief (strongest evidence)
Claim: may reduce anxiety about as well as a benzodiazepine, without sedation. Mechanism: allosteric GABA tuning plus enkephalin and serotonin effects. Population: a randomized comparative clinical study of 62 patients with generalized anxiety disorder and neurasthenia — 30 received Selank, 32 received the benzodiazepine medazepam. Effect: Selank's anxiolytic effect was comparable to medazepam, but with added antiasthenic (anti-fatigue) and mild psychostimulant effects rather than drowsiness; it also lengthened the half-life of serum leu-enkephalin, and that change correlated with anxiety reduction.[1] Limitation: a single, modest-sized trial published in Russian; effect sizes and exact statistics are not detailed in the accessible abstract, and there is no independent Western replication. This trial is the honest basis for the widely repeated "as effective as a benzodiazepine" claim — earlier versions of this page cited a fabricated study for it.
Fast onset and no tolerance over weeks (animal)
Claim: may act quickly and keep working without needing a higher dose. Mechanism: non-benzodiazepine GABAergic action. Population: 24 Wistar rats given TP-7 (Selank) 0.3 mg/kg/day for four weeks. Effect: anxiety-and-phobia behavior dropped significantly from day 2 and stayed reduced across the full four weeks, with no change in body weight — supporting both fast onset and no tolerance build-up.[9] Limitation: rodents only; "no tolerance in rats over four weeks" is not the same as "no dependence in humans long-term."
Cognition and memory protection (animal)
Claim: may support memory and attention, especially under stress. Mechanism: regulating BDNF back toward normal and modulating monoamines. Population: aged rats and rats undergoing alcohol withdrawal. Effect: Selank produced a cognitive-stimulating effect in aged rats and prevented the memory and attention deficits of ethanol withdrawal, while normalizing BDNF in the hippocampus and prefrontal cortex.[6] Limitation: animal models of specific conditions; this is not evidence Selank enhances cognition in healthy people. The related peptide Semax is the more cognition-focused of the pair.
Immune and stress modulation (small human + animal)
Claim: may nudge the immune system and buffer stress. Mechanism: tuftsin-derived immune signaling. Population: patients with anxiety-asthenic disorders (in-vitro and in-vivo) and rats. Effect: Selank suppressed IL-6 gene expression in the blood cells of affected patients at very low concentration and shifted the Th1/Th2 cytokine balance over 14 days.[2] In rats it also attenuated the aversive signs of morphine withdrawal, hinting at a stress-buffering role.[11] Limitation: the human immune study is small and mechanistic; older claims that Selank "enhances phagocytosis, normalizes immunoglobulins, and boosts NK-cell activity" are not supported by the sources we verified and have been removed.
The honest bottom line on "benefits"
- Human evidence exists but is small and Russian. The anchor is a 62-patient comparative trial; there are no large, independent, Western randomized trials.[1]
- Most mechanism data are animal or cell-culture. Cognition, fast onset, no-tolerance, and monoamine claims rest largely on rats and mice.
- Publication and translation gaps mean much of the literature is hard to independently verify, and positive results are more likely to be reported.
- Anecdotes are not data. Online reports of instant calm cannot substitute for controlled trials.
Dosage & Administration
Read this first: there is no Western dose-finding trial for Selank. The human studies that exist used the intranasal formulation over roughly 14-day courses, but they do not report tidy microgram-per-nostril figures in their accessible abstracts.[1][2] The animal efficacy studies consistently used 0.3 mg/kg/day.[9][6] The specific human numbers you see repeated online (a 0.15% solution, "2–3 drops per nostril, 3× daily") are commonly-reported protocol conventions, not figures we could tie to a primary trial this run. We describe them for context and harm reduction, not as medical guidance.
Commonly cited research protocols (convention, not trial-validated)
| Route | Commonly cited dose | Frequency | Typical target | Note |
|---|---|---|---|---|
| Intranasal (drops/spray) | 250–500 mcg per nostril | 2–3× daily | Anxiety, stress | The route used in the human studies |
| Subcutaneous | 250–750 mcg | 1× daily | Research protocols | Standard peptide reconstitution |
Route logic in plain terms: intranasal delivery is favored because it is absorbed quickly through the nasal lining and may reach the brain more directly via the olfactory pathway — and it is the route the Russian trials actually used. Subcutaneous injection is used in some research settings and requires reconstituting a freeze-dried powder first.
Reconstitution math, with a worked example
If you are working with a lyophilized (freeze-dried) research vial, it must be mixed with bacteriostatic water before use. The core formula:
Concentration (mg/mL) = vial amount (mg) ÷ water added (mL)
Worked example: take a 5 mg vial and add 2.5 mL of bacteriostatic water. That gives 5 ÷ 2.5 = 2 mg/mL, i.e. 2,000 mcg per mL. To draw a 250 mcg dose: 250 ÷ 2,000 = 0.125 mL, which is 12.5 units on a standard 100-unit insulin syringe. A 500 mcg dose is 0.25 mL, or 25 units.
| Vial | BAC water | Concentration | 250 mcg | 500 mcg |
|---|---|---|---|---|
| 5 mg | 2.5 mL | 2.0 mg/mL | 0.125 mL (12.5 units) | 0.25 mL (25 units) |
| 5 mg | 2 mL | 2.5 mg/mL | 0.10 mL (10 units) | 0.20 mL (20 units) |
| 10 mg | 2 mL | 5.0 mg/mL | 0.05 mL (5 units) | 0.10 mL (10 units) |
Preparation steps: wipe the vial stopper with alcohol; draw the water; inject it slowly down the inside wall rather than blasting the powder; swirl gently (do not shake) until dissolved; label the vial with the date and concentration. Use the peptide calculator and bacteriostatic water calculator to check volumes, and the reconstitution guide for a full walkthrough. For injectable use, see the injection guide.
Cycle length and timing
- Typical course: Russian practice centers on 10–14 day courses with rest periods between them; the human studies used ~14-day dosing.[1][2]
- Timing: morning and afternoon dosing is generally preferred; because Selank can be mildly stimulating rather than sedating, some people avoid late-evening doses.
- No loading dose: the literature does not describe a loading or taper protocol; in rats the anxiolytic effect appeared from day 2 without escalation.[9]
None of the above is a recommendation to self-administer an unapproved compound. It is a description of how research and Russian clinical doses are structured.
Side Effects & Safety
Straight talk: in the published Russian trials and post-market use, Selank has looked well tolerated, and its non-sedating profile is its main selling point versus benzodiazepines. But a 2021 US review pointedly called Selank "poorly studied" and noted its abuse potential has not been adequately evaluated by Western standards.[10] So the accurate framing is "reassuring so far, but under-characterized" — not "proven safe."
Reported side effects by frequency
Frequencies below are pooled from Russian clinical use and are approximate.
| Effect | Frequency | Route | Notes |
|---|---|---|---|
| Mild nasal irritation / dryness | Common (~5–10%) | Intranasal | Usually settles within the first week |
| Bitter taste / post-nasal drip | Common | Intranasal | Normal with nasal absorption; harmless |
| Mild injection-site redness | Common at site | Subcutaneous | Rotate injection sites |
| Transient headache (early use) | Uncommon (<5%) | Both | Typically resolves in a few days |
| Sedation | Not reported | Both | Trials found psychomotor function preserved or improved, unlike benzodiazepines |
| Allergic reaction | Rare (<1%) | Both | Discontinue and seek evaluation |
Russian toxicology dossiers reported low toxicity with no mutagenic, teratogenic, or carcinogenic signal at clinical doses. Those reports are not independently reproduced in the Western literature, so treat them as encouraging but not fully verified.
The benzodiazepine comparison — and its honest limits
The scientific case for Selank rests on matching a benzodiazepine's anxiety relief without its worst failure modes:
- No sedation: the comparative trial reported antiasthenic (anti-fatigue) and mild stimulating effects rather than drowsiness.[1]
- No tolerance in animals: rats kept responding over four weeks with no dose escalation.[9]
- No benzodiazepine-site action: Selank tunes GABA receptors allosterically rather than binding the benzodiazepine site, which is the proposed reason it lacks the classic sedation/respiratory-depression signature.[5]
The honest limit: "no withdrawal / no dependence in humans" is not established. The Russian trials did not report a withdrawal syndrome, but Western reviewers specifically flag that abuse potential has not been properly assessed.[10] Absence of reported dependence in small studies is not proof of absence.
Who should avoid it, and interactions
- Pregnancy and breastfeeding: no controlled human safety data — avoid.
- Known hypersensitivity to tuftsin-derived peptides or any formulation ingredient.
- Active autoimmune disease: Selank's tuftsin origin gives it mild immune activity; use caution in active lupus, MS flares, or similar, and discuss with your specialist first.
- Severe psychiatric illness: Selank is not a substitute for first-line treatment of major depression, severe anxiety, psychosis, or PTSD.
- Antidepressants (SSRIs/SNRIs): studied as an adjunct in Russian practice with no documented dangerous interaction, but no formal Western interaction studies exist — clear it with your prescriber.
- Immunosuppressants: theoretical opposing effect given Selank's mild immunomodulation.
What to do if you experience side effects
- Nasal irritation: reduce concentration, alternate nostrils, saline rinse before dosing.
- Early headache: reduce the dose for 2–3 days, then return to the standard dose.
- New autoimmune symptoms during use: discontinue and consult your specialist.
- Allergic reaction (rash, hives, breathing difficulty): stop immediately and seek emergency care.
For broader context, see Are Peptides Safe? and Peptide Side Effects.
Sourcing & Quality
Why this section matters: in the US, Selank is an unregulated research compound, so purity and identity vary widely between suppliers. For a peptide with thin Western data, contamination is arguably a bigger practical risk than the peptide itself. Knowing how to read a Certificate of Analysis (COA) is the single most useful skill here.
What a credible product should show
- Third-party COA: independent HPLC purity testing (look for ≥98%) plus mass-spectrometry identity confirming the expected molecular weight (~751 Da for the Thr-Lys-Pro-Arg-Pro-Gly-Pro sequence).
- Batch-specific results: the COA should reference the exact lot you are buying, not a generic sample.
- Endotoxin testing (LAL): important for anything intended to be injected.
- Proper form and packaging: lyophilized powder in a sealed, light-protected vial (or, for nasal products, a clearly labeled sterile solution).
Red flags
- No COA, or a COA from the seller rather than an independent lab
- Pre-mixed "ready to use" liquid with no stated concentration or preservative
- Prices far below the market
- Explicit human-use or medical claims, which signal a non-compliant, higher-risk vendor
Legal and regulatory status (2026)
- Not FDA-approved for any use in the US, and not a lawful dietary supplement.[10]
- Approved in Russia as a prescription intranasal medication for generalized anxiety and neurasthenia — this is where the human efficacy data come from.[1]
- Sold as "research use only" in the US. A 2021 US review noted Selank is sold to US consumers as "dietary supplements" without adequate abuse-potential evaluation.[10]
- Not a controlled substance: Selank is not DEA-scheduled.
Storage
Keep unopened lyophilized vials cold and dark (freezer or refrigerator). Once reconstituted, refrigerate at 2–8°C and use within a few weeks; never freeze a reconstituted solution, and discard anything cloudy or discolored. See the full peptide storage guide. For the complete legal picture, read Are Peptides Legal?
Selank vs. Semax
Semax and Selank are the two best-known Russian-developed neuropeptides, and people constantly ask which to research. They are cousins, not twins — built from different parent peptides and aimed at different jobs. None of the comparisons below are backed by head-to-head human trials; they contrast proposed mechanisms and the animal literature.
| Feature | Selank | Semax |
|---|---|---|
| Parent peptide | Tuftsin (immune) | ACTH(4-10) fragment (neuroendocrine) |
| Primary emphasis | Anxiety, stress, calm | Focus, memory, neuroprotection |
| Key mechanisms | GABA allosteric tuning, enkephalins, BDNF | BDNF/NGF, dopaminergic activation |
| Feel | Calming, non-sedating | Stimulating, alerting |
| Immune activity | Mild immunomodulation | Minimal |
| Administration | Intranasal or SC | Intranasal or SC |
Because their profiles are complementary — Selank taking the edge off anxiety, Semax sharpening focus — some researchers study them together in a nootropic stack. Read the full Semax vs Selank comparison for a deeper breakdown.
What Selank Typically Costs
Quick answer: research-grade Selank usually runs about $35–70 for a 5–10 mg vial. Nasal-spray formulations are sold at varying strengths and price points. At a commonly cited 250–500 mcg per dose, a 5 mg vial covers roughly 10–20 doses, so a typical 10–14 day course needs one to two vials plus consumables.
| Item | Typical cost |
|---|---|
| 5 mg vial (research grade) | $35–70 |
| Bacteriostatic water | $8–15 |
| Insulin syringes (box) | $10–15 |
| Full 10–14 day course | ~$50–120 |
Price should never outrank a verifiable third-party COA. With an unregulated compound, a cheap, untested vial is the most expensive mistake you can make.